Home NefroDiab

NefroDiab

by Nume Prenume

NefroDiab

by Nume Prenume

May 10th-11th 2019, Hotel Kronwell, Brasov

Scientific event organized by the Romanian Society of Diabetes, Nutrition and Metabolic Diseases in partnership with the Romanian Society of Nephrology.

Conference subjects:

• The role of SGLT2 inhibitors in renal and cardiovascular protection

• Protein malnutrition in patients with diabetic kidney disease

• The effect of intensive glycemic control on the risk of chronic kidney disease in patients with diabetes

• Renal effects of incretin medication

• Metformin in chronic kidney disease

• Management of type 2 diabetes in the elderly with fragility syndrome and / or chronic kidney disease

• What is the benefit of kidney transplantation in dialysis patients?

• Control of obesity in diabetic patients with kidney disease

• Can chronic kidney disease be prevented by lifestyle changes?

• Diet control and energy consumption in diabetic patients with kidney disease: the point of view of the diabetologist and nephrologist

• Aging, obesity, kidney and diabetes: molecular links and clinical implications

• What is the best way to treat polyneuropathy in patients with diabetes and kidney failure?

• Should patients with chronic stage 5 kidney disease and diabetes start with peritoneal dialysis or hemodialysis?

• Oral medications: is one superior to another in terms of mortality / complications / glycemic control in diabetic patients with renal impairment or dialysis?

• Improving the management of type 1 diabetes: glycemic sensors, insulin pumps or both?

• Should antiplatelet therapy be recommended in diabetic patients with renal impairment regardless of cardiovascular risk?

More details on www.nefrodiab.ro

10-11 mai 2019, Hotel Kronwell, Brasov

Eveniment stiintific organizat de Societatea Romana de Diabet, Nutritie si Boli Metabolice si de Societatea Romana de Nefrologie.

Creditat cu ore de Educatie Medicala Continua de Colegiul Medicilor din Romania.

Din tematica Conferintei:
• Rolul inhibitorilor SGLT2 in protectia renala si cardiovasculara
• Denutritia proteica la pacientii cu boală renala diabetic
• Efectul controlului glicemic intensiv asupra riscului de aparitie a bolii renale cronice la pacientii cu diabet zaharat
• Efectele renale ale medicatiei incretinice
• Metforminul in boala renala cronica
• Managementul diabetului zaharat tip 2 la varstnici cu sindrom de fragilitate si/sau boala renala cronică
• Care este beneficiul transplantului renal la pacientii cu diabet zaharat dializati?
• Controlul obezitătii la pacientii diabetici cu boli renale
• Boala cronică de rinichi poate fi prevenită prin schimbarea stilului de viată?
• Controlul dietei si consumul de energie la pacientii diabetici cu boli renale: punctul de vedere al diabetologului si al nefrologului
• Imbătranirea, obezitatea, rinichiul si diabetul: legături moleculare si implicatii clinice
• Care este cea mai bună metodă de tratare a polineuropatiei la pacientii cu diabet si insuficienta renala?
• Pacientii cu boală cronica de rinichi stadiul 5 si diabet ar trebui sa inceapa cu dializa peritoneala sau cu hemodializa?
• Medicametele orale: este vreunul superior altuia in ceea ce priveste mortalitatea/complicatiile/controlul glicemic la pacientii diabetici cu insuficientă renală sau dializati?
• Imbunătătirea managementului diabetului de tip 1: senzori glicemici, pompe de insulina sau ambele?
• Terapia antiplachetara ar trebui recomandata la pacientii diabetici cu insuficienta renala indiferent de riscul cardiovascular?

Detalii pe www.nefrodiab.ro

error: Content is protected !!